scorecardresearch
Friday, September 12, 2025
TopicCancer treatment

Topic: Cancer treatment

SubscriberWrites: The Tightrope of Breaking Bad News

A dilemma between hope and honesty

How cancer daycare centres promised in Budget 2025 aim to ease treatment costs, access

Cancer care in India is marked by barriers of access & disparities in availability of quality care. Daycare centres at district hospitals could save patients up to Rs 10,000 cr annually.

After Sidhu claims diet changes helped his wife beat cancer, doctors warn against unscientific cures

Navjot Singh Sidhu says his wife, diagnosed with stage 4 breast cancer, followed a diet that included neem, turmeric, sour fruits. Oncologists say complementary therapies not treatment.

India relied on Western data for cancer care. Now, a platform pulls data from Indian patients

Definite steps are now being taken to understand the profile of cancer in the Indian population. Expect rapid progress in cancer care in India in the coming years.

Don’t let foreign big pharma block biosimilars. Govt should boost access in India

Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.

India gets 1st homegrown CAR T-cell therapy centre at IIT-B. All about breakthrough cancer treatment

CAR T-cell therapy's a form of immunotherapy that uses body's immune cells called T-cells, a type of lymphocyte or white blood cell. It has been approved for various types of blood cancers.

Pill under Rs 100 to reduce cancer recurrence? Novel nutraceutical holds promise but it’s too early

Findings by Tata Memorial Centre suggest that resveratrol, when given with miniscule doses of copper, can reduce rate of metastasis & treatment-related toxicity in cancer patients.

All about India’s 1st ‘living drug’ that uses patient’s own genetically engineered cells to fight cancer

Patients already registering for CAR T-cell therapy, developed indigenously by ImmunoACT under the name NexCAR19. It will be used to treat leukemia & refractory or relapsed lymphoma.

Combination of 2 immunotherapy drugs can help liver cancer patients live longer, finds India study

Done by researchers from Hyderabad's Asian Institute of Gastroenterology & Jaipur's Mahatma Gandhi Medical College, study was published in 'Journal of Clinical & Experimental Hepatology'.

Tata Memorial Centre-led project makes waves with promise to cut cancer drug costs by up to 99%

23 hospitals from National Cancer Grid, a network of over 250 cancer centres, pilot ‘pooled procurement’ to improve negotiability for high-value oncology and supportive-care drugs.

On Camera

Coup, conspiracy & the foreign hand—What Indian TV news channels saw in Nepal this week

‘Gen Z v/s Govt’ TV news coverage went for two days—not sure about the source of the telecast from Kathmandu since no credit was given.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

Navy gets first Tata-made Spanish 3D surveillance radar for its warships, 19 more to come

It is one of the most advanced long-range air defence and anti-missile radars. It has been acquired under an about USD 145-million deal signed in 2020.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?